-
2 days ago | 
openaccessgovernment.org | Monet Bailey
A HSSIB report highlights ongoing failures to act on safety recommendations, with repeated issues across mental health care services
-
1 month ago | 
openaccessgovernment.org | Monet Bailey
Researchers from the University of Cambridge have designed a handheld device that could potentially replace stethoscopes in heart valve disease screening A team from the University of Cambridge has developed a device that makes heart sound recording accurate and accessible, suitable for heart valve disease detection.
-
1 month ago | 
openaccessgovernment.org | Monet Bailey
New research from the International Diabetes Federation (IDF) has revealed that one in nine adults is living with diabetes The IDF has revealed that 589 million people are now living with diabetes, and within this figure, an estimated 252 million people are not aware they have the condition. Many people will be diagnosed when they already have one or more complications and will have missed opportunities to prevent or delay their onset.
-
1 month ago | 
openaccessgovernment.org | Monet Bailey
The UK Government has announced £20m to support drone operations for emergency services and eco-friendly flying taxis The Aviation Minister confirmed today (1 April 2025) that commercial-scale drone services and flying taxis could soon be a reality, following a £20m investment to launch new flight technologies. The new funding will propel the UK to growth, which is a priority of the Plan for Change.
-
1 month ago | 
openaccessgovernment.org | Monet Bailey
Patients will benefit from new pharmacy services, as the Government and Community Pharmacy England (CPE) agree on a £617m investment The UK Government has announced significant funding to help community pharmacies expand services and improve patient care. The full-year funding package is the first agreed upon by the sector since 2023, marking the government's initial steps in introducing its Plan for Change.
-
Dec 10, 2024 | 
healtheuropa.com | Monet Bailey
Chiesi Group’s unwavering commitment to both patient care and environmental sustainability sets a new standard in the pharmaceutical industry. Through science-driven initiatives, Chiesi aims to achieve net-zero emissions by 2035, while raising awareness about the critical link between climate change and respiratory health. Their ‘Action Over Words’ campaign exemplifies this commitment by educating the public, fostering collaboration, and supporting vulnerable communities.
-
Nov 25, 2024 | 
healtheuropa.com | Monet Bailey
Defence Therapeutics Inc. (CSE: DTC, OTCQB: DTCFF, FSE: DTC) is pleased to announce that Dr Maxime Parisotto has joined the Company as Chief Scientific Officer, Director of Science and Business Development. Dr Maxime Parisotto is a seasoned biochemist with over 20 years of experience spanning academic research, drug development, and innovation.
-
Nov 15, 2024 | 
healtheuropa.com | Monet Bailey
Chiesi Group has been named one of the 25 World’s Best Workplaces™ in 2024 by Great Place To Work® (GPTW) and Fortune magazine, ranking 23rd on this year’s list. This is the first time that Chiesi has been included in the GPTW global list, making it the first Italian company to achieve this honour. Headquartered in Parma, Italy, the Group has 31 affiliates worldwide and employs over 7,000 people, 56% of whom are women. More than 1,300 employees are dedicated to R&D.
-
Oct 30, 2024 | 
healtheuropa.com | Monet Bailey
Chiesi Group, a research-oriented international biopharmaceutical group, is proud to announce the official launch of The Impulse, an innovation platform designed to accelerate bold ideas and meaningful partnerships in healthcare. The Impulse aims to tackle some of the biggest challenges facing patients, the planet, and people today by addressing not only symptoms but also the root causes of these challenges, such as climate change and access to care.
-
Oct 24, 2024 | 
healtheuropa.com | Monet Bailey
In the UK, some 25,000 people are thought to have CMT (Charcot-Marie-Tooth disease), making it the most common inherited neurological condition. However, many people are not aware of CMT disease, even within the medical profession, which can make everyday living and early medical diagnosis more difficult. In a recent survey created by charity CMTUK, of over 300 respondents living with CMT in the UK, 67% felt that less than 10% of the UK population has heard of CMT disease.
